HC Wainwright keeps Buy on Tyra Biosciences, targets $29
HC Wainwright & Co. maintained a Buy rating on Tyra Biosciences and reiterated a $29.00 price target, implying 13.1% upside versus the Sep 21 close of $25.65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.